Agostini F - Search Results

1

Nonalcoholic fatty liver disease and the metabolic syndrome.

Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Marchesini G, et al. Among authors: agostini f. Curr Opin Lipidol. 2005 Aug;16(4):421-7. doi: 10.1097/01.mol.0000174153.53683.f2. Curr Opin Lipidol. 2005. PMID: 15990591 Review.

2

Review article: the treatment of fatty liver disease associated with the metabolic syndrome.

Marchesini G, Natale S, Manini R, Agostini F. Marchesini G, et al. Among authors: agostini f. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:37-9. doi: 10.1111/j.1365-2036.2005.02593.x. Aliment Pharmacol Ther. 2005. PMID: 16225470 Review.

3

Update on nutritional supplementation with branched-chain amino acids.

Bianchi G, Marzocchi R, Agostini F, Marchesini G. Bianchi G, et al. Among authors: agostini f. Curr Opin Clin Nutr Metab Care. 2005 Jan;8(1):83-7. doi: 10.1097/00075197-200501000-00013. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15586005 Review.

4

Update on branched-chain amino acid supplementation in liver diseases.

Bianchi G, Marzocchi R, Agostini F, Marchesini G. Bianchi G, et al. Among authors: agostini f. Curr Opin Gastroenterol. 2005 Mar;21(2):197-200. doi: 10.1097/01.mog.0000153353.45738.bf. Curr Opin Gastroenterol. 2005. PMID: 15711213 Review.

5

Treatment of non-alcoholic fatty liver disease with focus on emerging drugs.

Marchesini G, Moscatiello S, Agostini F, Villanova N, Festi D. Marchesini G, et al. Among authors: agostini f. Expert Opin Emerg Drugs. 2011 Mar;16(1):121-36. doi: 10.1517/14728214.2011.531700. Expert Opin Emerg Drugs. 2011. PMID: 21352073 Review.

6

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control.

Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G. Di Pierro F, et al. Among authors: agostini f. Diabetes Metab Syndr Obes. 2012;5:213-7. doi: 10.2147/DMSO.S33718. Epub 2012 Jul 17. Diabetes Metab Syndr Obes. 2012. PMID: 22924000 Free PMC article.

7

Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.

Sasdelli AS, Agostini F, Pazzeschi C, Guidetti M, Lal S, Pironi L. Sasdelli AS, et al. Among authors: agostini f. Clin Nutr. 2019 Jun;38(3):1198-1205. doi: 10.1016/j.clnu.2018.04.019. Epub 2018 May 8. Clin Nutr. 2019. PMID: 29778510

8

Intravenous lipids in home parenteral nutrition.

Pironi L, Agostini F, Guidetti M. Pironi L, et al. Among authors: agostini f. World Rev Nutr Diet. 2015;112:141-9. doi: 10.1159/000365608. Epub 2014 Nov 24. World Rev Nutr Diet. 2015. PMID: 25471810 Review.

9

Iodine status in intestinal failure in adults.

Pironi L, Guidetti M, Agostini F. Pironi L, et al. Among authors: agostini f. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):582-7. doi: 10.1097/MCO.0000000000000217. Curr Opin Clin Nutr Metab Care. 2015. PMID: 26335309 Review.

10

Iodine nutrition in adults on long-term home parenteral nutrition.

Guidetti M, Agostini F, Lapenna G, Pazzeschi C, Soverini V, Petitto R, Pironi L. Guidetti M, et al. Among authors: agostini f. Nutrition. 2014 Sep;30(9):1050-4. doi: 10.1016/j.nut.2014.03.012. Epub 2014 Apr 3. Nutrition. 2014. PMID: 25102820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters